Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Rizzi

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Autoimmunity|May 7, 2014
Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory diseaseNils Venhoff, Lena Niessen, Matthias Kreuzaler, et al.
Journal of Autoimmunity|March 14, 2019
Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - A report of two casesSarah Wendel, Nils Venhoff, Bjoern C Frye, et al.
Frontiers in Immunology|March 6, 2023
Lymphoid stromal cells - potential implications for the pathogenesis of CVIDVictoria N Cousin, Guillermo F Perez, Kathryn J Payne, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 17, 2017
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up AnalysisJens Thiel, Arianna Troilo, Ulrich Salzer, et al.
Haematologica|November 16, 2014
Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiencyPolina Stepensky, Baerbel Keller, Omar Abuzaitoun, et al.
Cell Death & Disease|February 10, 2017
Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signallingCristian R Smulski, Marion Decossas, Neila Chekkat, et al.
Arthritis and Rheumatism|May 29, 2007
Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptideFrancesca Ferrera, Bevra H Hahn, Marta Rizzi, et al.
The Journal of Allergy and Clinical Immunology|July 28, 2016
Disturbed canonical nuclear factor of κ light chain signaling in B cells of patients with common variable immunodeficiencyBaerbel Keller, Zoltan Cseresnyes, Ina Stumpf, et al.
Frontiers in Immunology|May 23, 2019
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B LymphocytesJulian Staniek, Raquel Lorenzetti, Bianca Heller, et al.
Frontiers in Immunology|April 4, 2019
The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral InvolvementNils Venhoff, Jens Thiel, Marta Rizzi, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Autoimmunity|May 7, 2014
Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory diseaseNils Venhoff, Lena Niessen, Matthias Kreuzaler, et al.
Journal of Autoimmunity|March 14, 2019
Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - A report of two casesSarah Wendel, Nils Venhoff, Bjoern C Frye, et al.
Frontiers in Immunology|March 6, 2023
Lymphoid stromal cells - potential implications for the pathogenesis of CVIDVictoria N Cousin, Guillermo F Perez, Kathryn J Payne, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 17, 2017
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up AnalysisJens Thiel, Arianna Troilo, Ulrich Salzer, et al.
Haematologica|November 16, 2014
Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiencyPolina Stepensky, Baerbel Keller, Omar Abuzaitoun, et al.
Cell Death & Disease|February 10, 2017
Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signallingCristian R Smulski, Marion Decossas, Neila Chekkat, et al.
Arthritis and Rheumatism|May 29, 2007
Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptideFrancesca Ferrera, Bevra H Hahn, Marta Rizzi, et al.
The Journal of Allergy and Clinical Immunology|July 28, 2016
Disturbed canonical nuclear factor of κ light chain signaling in B cells of patients with common variable immunodeficiencyBaerbel Keller, Zoltan Cseresnyes, Ina Stumpf, et al.
Frontiers in Immunology|May 23, 2019
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B LymphocytesJulian Staniek, Raquel Lorenzetti, Bianca Heller, et al.
Frontiers in Immunology|April 4, 2019
The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral InvolvementNils Venhoff, Jens Thiel, Marta Rizzi, et al.
Pageof 10